Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Solid pancreas transplant: Pushing forward.

Giorgakis E, Mathur AK, Chakkera HA, Reddy KS, Moss AA, Singer AL.

World J Transplant. 2018 Nov 30;8(7):237-251. doi: 10.5500/wjt.v8.i7.237. Review.

2.

Cardiorespiratory Fitness (Peak Oxygen Uptake): Safe and Effective Measure for Cardiovascular Screening Before Kidney Transplant.

Chakkera HA, Angadi SS, Heilman RL, Kaplan B, Scott RL, Bollempalli H, Cha SS, Khamash HA, Huskey JL, Mour GK, Sukumaran Nair S, Singer AL, Reddy KS, Mathur AK, Moss AA, Hewitt WR Jr, Qaqish I, Behmen S, Keddis MT, Unzek S, Steidley DE.

J Am Heart Assoc. 2018 May 31;7(11). pii: e008662. doi: 10.1161/JAHA.118.008662.

3.

Transplantation crisis at the time of economic recession in Greece.

Giorgakis E, Singer AL, Khorsandi SE, Prachalias A.

Public Health. 2018 Jul;160:125-128. doi: 10.1016/j.puhe.2018.03.031. Epub 2018 May 26.

PMID:
29803187
4.

Hospitalizations for Cardiovascular Disease After Liver Transplantation in the United States.

Khurmi NS, Chang YH, Eric Steidley D, Singer AL, Hewitt WR, Reddy KS, Moss AA, Mathur AK.

Liver Transpl. 2018 Oct;24(10):1398-1410. doi: 10.1002/lt.25055.

PMID:
29544033
5.

PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force.

Hobeika MJ, Miller CM, Pruett TL, Gifford KA, Locke JE, Cameron AM, Englesbe MJ, Kuhr CS, Magliocca JF, McCune KR, Mekeel KL, Pelletier SJ, Singer AL, Segev DL.

Am J Transplant. 2017 Oct;17(10):2546-2558. doi: 10.1111/ajt.14441. Epub 2017 Sep 2.

6.

Hospital resource intensity and cirrhosis mortality in United States.

Mathur AK, Chakrabarti AK, Mellinger JL, Volk ML, Day R, Singer AL, Hewitt WR, Reddy KS, Moss AA.

World J Gastroenterol. 2017 Mar 14;23(10):1857-1865. doi: 10.3748/wjg.v23.i10.1857.

7.

Progression of Interstitial Fibrosis during the First Year after Deceased Donor Kidney Transplantation among Patients with and without Delayed Graft Function.

Heilman RL, Smith ML, Smith BH, Qaqish I, Khamash H, Singer AL, Kaplan B, Reddy KS.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2225-2232. Epub 2016 Oct 24.

8.

Do Patient Assessments of Hospital Quality Correlate With Kidney Transplantation Surgical Outcomes?

Chakrabarti AK, Sheetz KH, Katariya NN, Singer AL, Hewitt WR, Heilman RL, Khamash H, Reddy KS, Moss AA, Mathur AK.

Transplant Proc. 2016 Jul-Aug;48(6):1986-92. doi: 10.1016/j.transproceed.2016.03.038.

PMID:
27569933
9.

Chimeric Allografts Induced by Short-Term Treatment With Stem Cell Mobilizing Agents Result in Long-Term Kidney Transplant Survival Without Immunosuppression: II, Study in Miniature Swine.

Cameron AM, Wesson RN, Ahmadi AR, Singer AL, Hu X, Okabayashi T, Wang Y, Shigoka M, Fu Y, Gao W, Raccusen LC, Montgomery RA, Williams GM, Sun Z.

Am J Transplant. 2016 Jul;16(7):2066-76. doi: 10.1111/ajt.13703. Epub 2016 Mar 22.

10.

Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi After Deceased Donor Kidney Transplantation.

Batra RK, Heilman RL, Smith ML, Thomas LF, Khamash HA, Katariya NN, Hewitt WR, Singer AL, Mathur AK, Huskey J, Chakkera HA, Moss A, Reddy KS.

Am J Transplant. 2016 Mar;16(3):1015-20. doi: 10.1111/ajt.13561. Epub 2015 Dec 21.

11.

Glucose homeostasis after simultaneous pancreas and kidney transplantation: a comparison of subjects with C-peptide-positive non-type 1 diabetes mellitus and type 1 diabetes mellitus.

Chakkera HA, Kudva YC, Chang YH, Heilman RL, Singer AL, Mathur AK, Hewitt WR, Khamash HA, Huskey JL, Katariya NN, Moss AA, Behmen S, Reddy KS.

Clin Transplant. 2016 Jan;30(1):52-9. doi: 10.1111/ctr.12658. Epub 2015 Nov 26.

PMID:
26485408
12.

Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation.

Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi BJ, Dagher NN, Singer AL, Carter-Monroe N, Nazarian SM, Segev DL, Streiff MB, Montgomery RA.

Am J Transplant. 2014 Feb;14(2):459-65. doi: 10.1111/ajt.12540. Epub 2014 Jan 8.

13.

Kidney Transplant Program at the Mayo Clinic in Arizona.

Heilman RL, Khamash HA, Huskey JL, Chakkera HA, Batra RK, Katariya NN, Singer AL, Mathur AK, Moss AA, Reddy KS.

Clin Transpl. 2014:61-8.

PMID:
26281128
14.

Transplantation: Alloantibodies in simultaneous liver-kidney transplantation.

Singer AL, Segev DL.

Nat Rev Nephrol. 2013 Jul;9(7):373-4. doi: 10.1038/nrneph.2013.84. Epub 2013 May 7. No abstract available.

PMID:
23649019
15.

Identifying appropriate recipients for CDC infectious risk donor kidneys.

Chow EK, Massie AB, Muzaale AD, Singer AL, Kucirka LM, Montgomery RA, Lehmann HP, Segev DL.

Am J Transplant. 2013 May;13(5):1227-34. doi: 10.1111/ajt.12206.

16.

Reply to "Defining the benefits of desensitization therapy".

Singer AL, Alachkar N, Montgomery RA, Zachary AA.

Transplantation. 2013 Mar 27;95(6):e33. doi: 10.1097/TP.0b013e3182845ffb. No abstract available.

PMID:
23507652
17.

The aggressive phenotype revisited: utilization of higher-risk liver allografts.

Garonzik-Wang JM, James NT, Arendonk KJV, Gupta N, Orandi BJ, Hall EC, Massie AB, Montgomery RA, Dagher NN, Singer AL, Cameron AM, Segev DL.

Am J Transplant. 2013 Apr;13(4):936-942. doi: 10.1111/ajt.12151. Epub 2013 Feb 15.

18.

Infusion of high-dose intravenous immunoglobulin fails to lower the strength of human leukocyte antigen antibodies in highly sensitized patients.

Alachkar N, Lonze BE, Zachary AA, Holechek MJ, Schillinger K, Cameron AM, Desai NM, Dagher NN, Segev DL, Montgomery RA, Singer AL.

Transplantation. 2012 Jul 27;94(2):165-71. doi: 10.1097/TP.0b013e318253f7b6.

PMID:
22735712
19.

Rescue kidney paired donation as emergency salvage for failed desensitization.

Sharif A, Zachary AA, Hiller J, Segev D, Alachkar N, Kraus ES, Desai NM, Dagher NN, Singer AL, Montgomery RA.

Transplantation. 2012 Apr 15;93(7):e27-9. doi: 10.1097/TP.0b013e318249b10e. No abstract available.

PMID:
22450596
20.

Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis.

Deshpande NA, James NT, Kucirka LM, Boyarsky BJ, Garonzik-Wang JM, Cameron AM, Singer AL, Dagher NN, Segev DL.

Liver Transpl. 2012 Jun;18(6):621-9. doi: 10.1002/lt.23416. Review.

21.

Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.

Lonze BE, Dagher NN, Liu M, Kucirka LM, Simpkins CE, Locke JE, Desai NM, Cameron AM, Montgomery RA, Segev DL, Singer AL.

Arch Surg. 2011 Nov;146(11):1261-6. doi: 10.1001/archsurg.2011.267.

PMID:
22106317
22.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

23.

Estimating the potential pool of HIV-infected deceased organ donors in the United States.

Boyarsky BJ, Hall EC, Singer AL, Montgomery RA, Gebo KA, Segev DL.

Am J Transplant. 2011 Jun;11(6):1209-17. doi: 10.1111/j.1600-6143.2011.03506.x. Epub 2011 Mar 28.

24.

High infectious risk donors: what are the risks and when are they too high?

Kucirka LM, Singer AL, Segev DL.

Curr Opin Organ Transplant. 2011 Apr;16(2):256-61. doi: 10.1097/MOT.0b013e3283449dd3. Review.

PMID:
21415830
25.

Outcomes and discard of kidneys from pediatric donors after cardiac death.

Dagher NN, Lonze BE, Singer AL, Simpkins CE, Desai NM, Montgomery RA, Segev DL.

Transplantation. 2011 Apr 15;91(7):765-71. doi: 10.1097/TP.0b013e31820cfd27.

PMID:
21285917
26.

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.

Locke JE, Singer AL.

Hepat Med. 2011 May 13;3:53-62. doi: 10.2147/HMER.S13682. Review.

27.

Improving distribution efficiency of hard-to-place deceased donor kidneys: Predicting probability of discard or delay.

Massie AB, Desai NM, Montgomery RA, Singer AL, Segev DL.

Am J Transplant. 2010 Jul;10(7):1613-20. doi: 10.1111/j.1600-6143.2010.03163.x.

28.

Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access.

Lonze BE, Dagher NN, Simpkins CE, Locke JE, Singer AL, Segev DL, Zachary AA, Montgomery RA.

Am J Transplant. 2010 Sep;10(9):2154-60. doi: 10.1111/j.1600-6143.2010.03191.x. Epub 2010 Jul 15.

29.

Eculizumab and renal transplantation in a patient with CAPS.

Lonze BE, Singer AL, Montgomery RA.

N Engl J Med. 2010 May 6;362(18):1744-5. doi: 10.1056/NEJMc0910965. No abstract available.

PMID:
20445191
30.

Underutilization of hepatitis C-positive kidneys for hepatitis C-positive recipients.

Kucirka LM, Singer AL, Ros RL, Montgomery RA, Dagher NN, Segev DL.

Am J Transplant. 2010 May;10(5):1238-46. doi: 10.1111/j.1600-6143.2010.03091.x. Epub 2010 Mar 26.

31.

Perioperative mortality and long-term survival following live kidney donation.

Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE, McBride MA, Montgomery RA.

JAMA. 2010 Mar 10;303(10):959-66. doi: 10.1001/jama.2010.237.

PMID:
20215610
32.

Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors.

Stewart ZA, Locke JE, Segev DL, Dagher NN, Singer AL, Montgomery RA, Cameron AM.

Liver Transpl. 2009 Dec;15(12):1688-95. doi: 10.1002/lt.21946.

33.

ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis.

Stewart ZA, Locke JE, Montgomery RA, Singer AL, Cameron AM, Segev DL.

Liver Transpl. 2009 Aug;15(8):883-93. doi: 10.1002/lt.21723.

34.

Subclinical rejection in stable positive crossmatch kidney transplant patients: incidence and correlations.

Kraus ES, Parekh RS, Oberai P, Lepley D, Segev DL, Bagnasco S, Collins V, Leffell M, Lucas D, Rabb H, Racusen LC, Singer AL, Stewart ZA, Warren DS, Zachary AA, Haas M, Montgomery RA.

Am J Transplant. 2009 Aug;9(8):1826-34. doi: 10.1111/j.1600-6143.2009.02701.x. Epub 2009 Jun 16.

35.

Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab.

Singer AL, Locke JE, Stewart ZA, Lonze BE, Hamilton JP, Scudiere JR, Anders RA, Rother RP, Brodsky RA, Cameron AM.

Liver Transpl. 2009 May;15(5):540-3. doi: 10.1002/lt.21714.

36.

ABO incompatible renal transplantation: a paradigm ready for broad implementation.

Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M.

Transplantation. 2009 Apr 27;87(8):1246-55. doi: 10.1097/TP.0b013e31819f2024.

PMID:
19384174
37.

Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants.

Stewart ZA, Lonze BE, Warren DS, Dagher NN, Singer AL, Montgomery RA, Segev DL.

Am J Transplant. 2009 May;9(5):1048-54. doi: 10.1111/j.1600-6143.2008.02545.x. Epub 2009 Mar 3.

38.

Kidney transplantation in previous heart or lung recipients.

Lonze BE, Warren DS, Stewart ZA, Dagher NN, Singer AL, Shah AS, Montgomery RA, Segev DL.

Am J Transplant. 2009 Mar;9(3):578-85. doi: 10.1111/j.1600-6143.2008.02540.x.

39.

The fate of anti-HLA antibody among renal transplantation recipients treated with bortezomib.

Lonze BE, Dagher NN, Simpkins CE, Singer AL, Segev DL, Zachary AA, Montgomery RA.

Clin Transpl. 2009:377-84.

PMID:
20524301
40.

Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death.

Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL.

Am J Transplant. 2009 Feb;9(2):286-93. doi: 10.1111/j.1600-6143.2008.02478.x. Epub 2008 Nov 27.

41.

Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation.

Stewart ZA, Cameron AM, Singer AL, Dagher NN, Montgomery RA, Segev DL.

Am J Transplant. 2009 Jan;9(1):217-21. doi: 10.1111/j.1600-6143.2008.02449.x. Epub 2008 Nov 4.

42.

The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection.

Locke JE, Magro CM, Singer AL, Segev DL, Haas M, Hillel AT, King KE, Kraus E, Lees LM, Melancon JK, Stewart ZA, Warren DS, Zachary AA, Montgomery RA.

Am J Transplant. 2009 Jan;9(1):231-5. doi: 10.1111/j.1600-6143.2008.02451.x. Epub 2008 Oct 31.

43.

Successful three-way kidney paired donation with cross-country live donor allograft transport.

Montgomery RA, Katznelson S, Bry WI, Zachary AA, Houp J, Hiller JM, Shridharani S, John D, Singer AL, Segev DL.

Am J Transplant. 2008 Oct;8(10):2163-8. doi: 10.1111/j.1600-6143.2008.02347.x.

44.

The high-risk donor: viral infections in solid organ transplantation.

Singer AL, Kucirka LM, Namuyinga R, Hanrahan C, Subramanian AK, Segev DL.

Curr Opin Organ Transplant. 2008 Aug;13(4):400-4. doi: 10.1097/MOT.0b013e3283094ba3. Review.

PMID:
18685336
45.

Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.

Locke JE, Warren DS, Dominici F, Cameron AM, Leffell MS, McRann DA, Melancon JK, Segev DL, Simpkins CE, Singer AL, Zachary AA, Montgomery RA.

J Am Soc Nephrol. 2008 Oct;19(10):2011-9. doi: 10.1681/ASN.2008010078. Epub 2008 Jul 23.

46.

Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.

Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, Montgomery RA, Danovitch G, Cameron AM.

Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d.

PMID:
18408571
47.

Persistence of cooperatively stabilized signaling clusters drives T-cell activation.

Bunnell SC, Singer AL, Hong DI, Jacque BH, Jordan MS, Seminario MC, Barr VA, Koretzky GA, Samelson LE.

Mol Cell Biol. 2006 Oct;26(19):7155-66.

48.

Functional hierarchy of the N-terminal tyrosines of SLP-76.

Jordan MS, Sadler J, Austin JE, Finkelstein LD, Singer AL, Schwartzberg PL, Koretzky GA.

J Immunol. 2006 Feb 15;176(4):2430-8.

49.

PRAM-1 is required for optimal integrin-dependent neutrophil function.

Clemens RA, Newbrough SA, Chung EY, Gheith S, Singer AL, Koretzky GA, Peterson EJ.

Mol Cell Biol. 2004 Dec;24(24):10923-32.

50.

Roles of the proline-rich domain in SLP-76 subcellular localization and T cell function.

Singer AL, Bunnell SC, Obstfeld AE, Jordan MS, Wu JN, Myung PS, Samelson LE, Koretzky GA.

J Biol Chem. 2004 Apr 9;279(15):15481-90. Epub 2004 Jan 13.

Supplemental Content

Loading ...
Support Center